Janakiraman Subramanian

Janakiraman Subramanian

UNVERIFIED PROFILE

Are you Janakiraman Subramanian?   Register this Author

Register author
Janakiraman Subramanian

Janakiraman Subramanian

Publications by authors named "Janakiraman Subramanian"

Are you Janakiraman Subramanian?   Register this Author

45Publications

628Reads

5Profile Views

Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer.

Expert Rev Anticancer Ther 2019 Jul 14;19(7):547-559. Epub 2019 Jun 14.

a Department of Medicine , University of Missouri Kansas City , Kansas City , MO , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2019.1596030DOI Listing
July 2019

Emergence of Mutation as a Biomarker and an Actionable Target in Solid Cancers.

Oncologist 2019 Jul 10. Epub 2019 Jul 10.

Molecular Medicine and Therapeutics Laboratory, Centre for Plant Molecular Biology, Osmania University, Hyderabad, India

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0845DOI Listing
July 2019

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer harboring uncommon EGFR mutations: Focus on afatinib.

Semin Oncol 2019 Jun 11;46(3):271-283. Epub 2019 Sep 11.

Division of Oncology, Saint Luke's Cancer Institute, Kansas City, MO; Center for Precision Oncology, Saint Luke's Cancer Institute, Kansas City, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2019.08.004DOI Listing
June 2019

Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications.

Semin Cancer Biol 2019 02 22;54:14-28. Epub 2017 Nov 22.

Department of Medicine, University of Missouri Kansas City School of Medicine, Kansas City, MO 64108, USA; Division of Oncology, Saint Luke's Cancer Institute, Kansas City, MO 64111, USA; Center for Precision Oncology, Saint Luke's Cancer Institute, Kansas City, MO 64111, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2017.11.016DOI Listing
February 2019

The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung.

J Thorac Oncol 2018 05 31;13(5):707-714. Epub 2018 Jan 31.

Department of Medicine/Division of Hematology and Oncology, University of Missouri Kansas City, Kansas City, Missouri; Division of Oncology, Saint Luke's Cancer Institute, Kansas City, Missouri. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.01.019DOI Listing
May 2018

Predictors for chemotherapy in early stage small cell lung carcinoma (SCLC): A National Cancer Database (NCDB) analysis.

Lung Cancer 2017 11 13;113:85-87. Epub 2017 Sep 13.

Department of Medicine, University of Missouri, Kansas City, MO 64108, USA; Division of Oncology, Saint Luke's Cancer Institute, Kansas City, MO 64111, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.09.004DOI Listing
November 2017

Disparities in the Management of Patients With Stage I Small Cell Lung Carcinoma (SCLC): A Surveillance, Epidemiology and End Results (SEER) Analysis.

Clin Lung Cancer 2017 09 30;18(5):e315-e325. Epub 2017 Mar 30.

Division of Oncology, Saint Luke's Cancer Institute, Kansas City, MO. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.03.003DOI Listing
September 2017

Genetic identification of marine eels through DNA barcoding from Parangipettai coastal waters.

Genom Data 2017 Mar 9;11:81-84. Epub 2016 Dec 9.

Centre of Advanced Study in Marine Biology, Faculty of Marine Sciences, Annamalai University, Tamil Nadu, India.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22135960163019
Publisher Site
http://dx.doi.org/10.1016/j.gdata.2016.12.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198627PMC
March 2017

DGIdb: mining the druggable genome.

Nat Methods 2013 Dec 13;10(12):1209-10. Epub 2013 Oct 13.

1] The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, USA. [2] Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, USA. [3].

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nmeth.2689DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851581PMC
December 2013

Molecular profile of lung cancer in never smokers.

EJC Suppl 2013 Sep;11(2):248-53

Washington University School of Medicine, Department of Medicine, St. Louis, USA ; Alvin J. Siteman Cancer Center at Washington University School of Medicine, St. Louis, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejcsup.2013.07.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041029PMC
September 2013

Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.

J Thorac Oncol 2012 Oct;7(10):1485-9

Department of Medicine, Division of Medical Oncology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318267223aDOI Listing
October 2012

Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trial.

Clin Lung Cancer 2012 Mar 18;13(2):123-8. Epub 2011 Nov 18.

Section of Hematology and Oncology, Department of Medicine, and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2011.10.001DOI Listing
March 2012

Optimising therapy for EGFR-addicted NSCLC: just the start.

Lancet Oncol 2012 Mar 26;13(3):216-7. Epub 2012 Jan 26.

Division of Oncology, Department of Medicine, and Alvin J Siteman Cancer Center, Washington University School of Medicine, St Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(12)70037-2DOI Listing
March 2012

A roundup of articles published in recent months.

J Thorac Oncol 2012 Mar;7(3):626-8

Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153257
Publisher Site
http://dx.doi.org/10.1097/JTO.0b013e3182436098DOI Listing
March 2012

Recent advances in lung cancer: summary of presentations from the 47 th annual meeting of the American Society of Clinical Oncology (ASCO) 2011.

J Thorac Oncol 2012 Jan;7(1):260-5

Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153178
Publisher Site
http://dx.doi.org/10.1097/JTO.0b013e31823a40a6DOI Listing
January 2012

Targeted therapy in lung cancer: lessons learned from past experiences.

J Thorac Oncol 2011 Nov;6(11 Suppl 4):S1786-8

Division of Oncology, Department of Medicine, and Alvin J Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153263
Publisher Site
http://dx.doi.org/10.1097/01.JTO.0000407558.38416.c5DOI Listing
November 2011

Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.

Clin Lung Cancer 2011 Mar 8;12(2):94-9. Epub 2011 Apr 8.

Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2011.03.003DOI Listing
March 2011

Summary of presentations from the 46th Annual Meeting of the American Society of Clinical Oncology (2010) focus on tumor biology and biomarkers related to lung cancer.

J Thorac Oncol 2011 Feb;6(2):399-403

Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318200f972DOI Listing
February 2011

Vascular endothelial growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.

Clin Lung Cancer 2010 Sep;11(5):311-9

Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2010.n.039DOI Listing
September 2010

Review of ongoing clinical trials in non-small cell lung cancer: a status report for 2009 from the ClinicalTrials.gov website.

J Thorac Oncol 2010 Aug;5(8):1116-9

Division of Oncology, Department of Medicine, Washington University School of Medicine, 660 S. Euclid, Box 8056, St Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181e76159DOI Listing
August 2010

Chemotherapy: continued lack of progress in SCLC.

Nat Rev Clin Oncol 2010 Feb;7(2):77-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2009.223DOI Listing
February 2010

Lung cancer in 'Never-smokers': a unique entity.

Oncology (Williston Park) 2010 Jan;24(1):29-35

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

View Article

Download full-text PDF

Source
January 2010

Improving survival for stage IV non-small cell lung cancer: a surveillance, epidemiology, and end results survey from 1990 to 2005.

J Thorac Oncol 2009 Dec;4(12):1524-9

Division of Hematology-Oncology, St. Louis Veterans Hospital, St. Louis, Missouri, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181ba3634DOI Listing
December 2009

Small cell, big problem! Stem cells, root cause?

Clin Lung Cancer 2008 Sep;9(5):252-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2008.n.039DOI Listing
September 2008

Molecular genetics of lung cancer in people who have never smoked.

Lancet Oncol 2008 Jul;9(7):676-82

Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(08)70174-8DOI Listing
July 2008

Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).

J Thorac Oncol 2007 Sep;2(9):827-30

Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S155608641530871
Publisher Site
http://dx.doi.org/10.1097/JTO.0b013e318145af79DOI Listing
September 2007

Lung cancer in never smokers: a review.

J Clin Oncol 2007 Feb;25(5):561-70

Department of Medicine and Alvin J. Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.06.8015DOI Listing
February 2007

Response to bortezomib (velcade) in a case of advanced bronchiolo-alveolar carcinoma (BAC). A case report.

Lung Cancer 2006 Feb 18;51(2):257-9. Epub 2006 Jan 18.

Department of Medicine, St Luke's Hospital, Chesterfield, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2005.10.007DOI Listing
February 2006